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ABSTRACT When human fibroblasts from different do-
nors are grown in vitro, only a small fraction of the variation
in their finite replicative capacity is explae by the chrono-
logical age of the donor. Because we had previously shown that
telomeres, the terminal guanine-rich sequences of chromo-
somes, shorten throughout the life-span of cultured cells, we
wished to determine whether variation in initial telomere length
would account for the unexplained variation in replicative
capacity. Analysis of cells from 31 donors (aged 0-93 yr)
indicated relatively weak correlations between proliferative
ability and donor age (m = -0.2 doubling per yr; r = -0.42;
P = 0.02) and between telomericDNA and donor age (m = -15
base pairs per yr; r = -0.43; P = 0.02). However, there was
a stiking correlation, valid over the entire age range of the
donors, between replicative capacity and initial telomere length
(m = 10 doublngs per kilobase pair; r = 0.76; P = 0.004),
indicating that cell strains with shorter telomeres underwent
slglcantiy fewer doublings than those with longer telomeres.
These observations suggest that telomere length is a biomarker
ofsomatic cell aging in humans and are consistent with a causal
role for telomere loss in this process. We also found that
fibroblasts from Hutchinson-Gilford progeria donors had
short telomeres, consistent with their reduced division potential
in vitro. In contrast, telomeres from sperm DNA did not
decrease with age ofthe donor, suggesting that a mechanism for
maintaining telomere length, such as telomerase expression,
may be active in germ-line tissue.
The cellular senescence model of aging was founded by
landmark experiments of Hayflick and Moorhead (1), who
firmly established that normal human fibroblasts have a finite
life-span in vitro. Although much evidence supports this
model (2-8), the mechanism accounting for the finite division
capacity of normal somatic cells remains a mystery. Olovni-
kov (9, 10) suggested that the cause of cellular senescence is
the gradual loss of telomeres due to the end-replication
problem-i.e., the inability of DNA polymerase to com-
pletely replicate the 3' end of linear duplex DNA (11) (for
review, see refs. 12 and 13).
Telomeres play a critical role in chromosome structure and
function. They prevent aberrant recombination (14-16) and
apparently function in the attachment ofchromosome ends to
the nuclear envelope (17). Telomeres are composed of simple
repetitive DNA (for review, see ref. 12), and in mammals this
sequence is (TTAGGG), (18). These telomeric repeats are
elongated by telomerase, a ribonucleoprotein enzyme that
extends the 3' end of telomeres (ref. 19; for review, see ref.
20). Thus, in immortal eukaryotic cells, telomerase appar-
ently balances telomere loss with de novo synthesis of
telomeric DNA.
Although it is clear that aging in cells, tissues, and organs
occurs at many levels and is polygenic (13, 21), several
observations implicate a role for telomere shortening in
replicative senescence of cells. (i) Telomeres shorten during
aging of cultured fibroblasts (22) and other somatic cells in
vivo, including skin epidermal cells (23) and peripheral blood
leukocytes and colon mucosa epithelia (24). In somatic cells,
telomere loss may be due to incomplete DNA replication in
the absence of telomerase (25, 26). (ii) There is an increased
frequency of chromosomal abnormalities, especially telo-
meric associations or dicentrics, in senescing fibroblasts
(27-29). Such chromosomal abnormalities are a hallmark of
terminal deletions (14). (iii) The presence of telomerase in
immortal cell lines (26, 30) correlates with stabilized telomere
lengths (26). (iv) The length ofsperm telomeres is greater than
that of somatic cells (31-33). These observations have led to
the telomere hypothesis of cellular aging (13), in which loss
of telomeres due to incomplete DNA replication and absence
of telomerase provides a mitotic clock that ultimately signals
cell cycle exit, limiting the replicative capacity of somatic
cells. To further explore this hypothesis, we have examined
the relationship between telomere length, in vivo age, and
replicative capacity of fibroblasts from normal donors and
subjects with the Hutchinson-Gilford syndrome of prema-
ture aging (34, 35). We have also determined the relationship
between telomere length in sperm DNA and donor age.
MATERIALS AND METHODS
Cell Culture. Skin samples from surgical specimens or
biopsy of various aged donors were cut into pieces 1 mm3 or
less in size and used to establish primary cultures (36). When
the first 100-mm dish reached confluence (-3 x 106 cells), the
cell population was assigned 16 population doublings. Except
as noted, DNA was analyzed from cultures at 19 population
doublings. All samples were coded at the time of tissue
collection, and the data on mean terminal restriction fragment
(TRF) length and culture life-span were collected without
knowledge of the donor age. Of the 43 independent strains
established and analyzed for TRF measurements (see Fig.
1C), 31 were selected at random for measurement of total
replicative capacity (see Fig. 2). Cells were considered se-
nescent when confluence (continuous monolayer) was not
reached after 4 weeks with weekly refeeding.
Isolation of Sperm DNA. Sperm pellets from 200 dul of
semen were washed in phosphate-buffered saline twice and
lysed in 200 .14 of 4 M guanidium isothiocyanate/0.1 M
mercaptoethanol/25 mM sodium citrate for 1 hr at 370C.
After extensive dialysis against proteinase K digestion buffer
Abbreviations: TRF, terminal restriction fragment; MPD, mean pop-
ulation doubling; Ho, null hypothesis.
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(100 mM NaCl/10 mM Tris, pH 8/5 mM EDTA/0.5% SDS),
proteinase K was added to the dialysate (final concentration,
0.2 mg/ml) and incubated at 480C overnight. Each sample
was extracted twice with 25:24:1 phenol/chloroform/
isoamyl alcohol, once with chloroform, and then ethanol
precipitated. Most semen samples were voluntary donations
from normal individuals after informed consent. Some sam-
ples were from the infertility clinic at McMaster University.
Only those samples having normal sperm count and mor-
phology were used in this study.
Analysis of DNA. DNA was digested with restriction en-
zymes Rsa I and Hinfl and quantified by fluorometry. One
microgram was resolved by electrophoresis in 0.5% agarose
gels for 600-700 V-hr. Hybridization of oligonucleotide
probes to dried gels was based on a modification of Mather
(37). In brief, gels were dried under vacuum at 600C for 45-60
min, soaked in 0.5 M NaOH/1.5 M NaCl for 10 min, then
soaked in 0.5 M Tris, pH 8/1.5M NaCI for 10 min, incubated
in 5 x standard saline/citrate (SSC) at 370C with 32P-end-
labeled (CCCTAA)3 for 8-12 hr, and finally washed three
times in 3 x SSC at 480C (10 min each) before exposure to
preflashed Kodak XAR film for 1-2 days. Mean TRF length
was determined from densitometric analysis of autoradio-
grams as described (22). In some experiments, dried gels
were directly analyzed by a PhosphorImager (Molecular
Dynamics, Sunnyvale, CA) with similar results. In these
experiments, the calculation of mean TRF length assumes
that the amount of telomeric DNA (TTAGGG repeats) in a
given TRF is proportional to the length of that TRF (22).
However, recent data suggest that a large and variable
fraction of the TRF is the non-TTAGGG component and that
it may be better not to normalize signal strength to TRF
length. Both methods, however, yield similar qualitative
conclusions with relatively minor changes in calculated mean
TRF length (data not shown).
RESULTS AND DISCUSSION
Telomere Length Decreases with Age in Vivo. Because there
is no reliable method of directly measuring telomere length in
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human cells, we and others have used mean TRF length to
detect changes in the length of the terminal TTAGGG arrays
(22-26, 30-33, 38, 39) (Fig. 1A). We have successfully used
this method of telomere-length analysis to show that telom-
eres shorten during replicative aging of human fibroblasts in
vitro (22, 25) and possibly in vivo (22). To firmly establish the
effect of chronological aging in vivo on telomere length in
fibroblasts, mean TRF length was determined for fibroblast
strains at equivalent passage established from 43 donors
ranging in age from 0 (fetal or newborn) to 93 yr (Fig. 1). A
small, but significant decrease in TRF length with age was
observed [15 ± 6 base pairs (bp) per yr; P = 0.01]. This loss
was accompanied by a decrease in hybridization signal
intensity (data not shown), indicating that the shortening of
fibroblast TRF length in vivo was from loss of TTAGGG
repeats, as was seen during aging of fibroblasts in vitro (22).
Similar results were reported by Lindsey et al. (23) for
telomere loss during aging of skin epidermal cells in vivo (20
± 7 bp per yr).
Mean TRF length of fibroblasts capable of proliferation in
vitro decreases =1.5 kbp during the life-span of humans (Fig.
1C). Because a substantial portion (=4-5 kbp, on average) of
the human fibroblast TRF is composed of subtelomeric
(non-TTAGGG) repeats (25, 26, 32), the loss of 1.5 kbp of
TTAGGG represents a significant fraction (>30%o) of the
initial telomeric DNA at birth. Overall, the mean TRF length
of cells from old donors (=7 kbp) is larger than that of
senescent cells in vitro (=6 kbp) (22, 25), consistent with the
significant replicative capacity of the cell population estab-
lished from these donors. Heterogeneity in the length of the
non-TTAGGG component in different telomeres (K. R.
Prowse, B. S. Abella, A.B.F., C.B.H., and C.W.G., unpub-
lished data), and the presence of some TTAGGG repeats in
the proximal region of the TRF can account for hybridization
of the telomeric probe to some TRFs shorter than 4-5 kbp
(Fig. 1B).
Telomere Length Predicts Replicative Capacity of Cells. In
vitro life-span of cells from unrelated donors (Fig. 2A)
decreases with age of the donor (2-8), but the correlation is
relatively weak (r = -0.42). Both interdonor genetic varia-
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FIG. 1. Mean TRF length decreases in skin fibroblasts with increased age of human donors. (A) The TRF is composed of distal telomeric
(TTAGGG) repeats (open bars), which hybridize to the telomeric probe, and other proximal sequences (solid bars), which do not. Arrowhead
indicates most distal Hinfl or Rsa I site. (B) Genomic DNA from fibroblast strains established from different donors of indicated ages was
prepared as described and resolved in agarose gels by electrophoresis. TRFs were detected with a 32P-labeled telomeric oligonucleotide. Size
[in kilobase pairs (kbp)] and position of markers are indicated. (C) Mean TRF length was calculated at the earliest possible passage for fibroblast
strains established from 43 normal donors ranging in age from 0 (fetal) to 93 yr. SDs for points representing the mean of two or more
determinations are indicated. The slope of the regression line is significantly different than 0. Values for the slope (m), regression coefficient
(r), and probability [P; null hypothesis (Ho): slope = 01 of the linear regression line are shown.
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FIG. 2. Replicative capacity is proportional to TRF length. TRF length (B) and remaining replicative capacity (mean population doublings,
MPD) after the initial 19 population doublings in culture (A) are shown as a function of donor age for a random subset of the strains tested in
Fig. 1C. From these data, replicative capacity was plotted as a function ofTRF length (C). Values for the slope (m), regression coefficient (r),
and probability (P; H.: slope = 0) of the linear regression lines are shown.
tion and clonal heterogeneity resulting from the variable in
vivo history of cells in a single donor probably contribute to
this weak correlation. Similarly, the correlation between
TRF length and donor age is also weak (Figs. 1C and 2B; r
=
-0.38 and -0.43, respectively). If telomere length were
causally linked to cellular life-span, then the initial telomere
length of the culture should correlate well with the life-span
of that culture, regardless of donor age. Of the 43 strains
analyzed for initial TRF length (Fig. 1), 31 strains were
selected at random (see Materials and Methods) for deter-
mination of in vitro life-span (Fig. 2A). When replicative
capacity was plotted as a function ofthe initial TRF length for
these strains, a much more significant correlation was found
(Fig. 2C; r = 0.76; P < 0.004) than that between replicative
life-span and donor age (Fig. 2A; r = -0.42; P < 0.02). To
show that initial TRF length explains a significant portion of
the variation in replicative capacity seen throughout the age
range of donors, different symbols were used to record the
data in Fig. 2 for donors in the age ranges 0-25 yr, 26-50 yr,
51-75 yr, and >75 yr. In each case, a clear correlation is seen
between replicative capacity and initial TRF length. This key
observation is important because it shows that TRF length is
a much better predictor of replicative capacity than is donor
age. Moreover, by providing a biomarker of cellular aging,
telomere length may prove useful in assessing whether rep-
licative senescence plays a role in age-related diseases and
loss of tissue function in vivo.
Telomere Length Is Reduced in Progeria Fibroblsts. Be-
cause replicative capacity is generally reduced in accelerated
aging syndromes (34, 35), we wanted to determine whether
telomeres are also shortened in these disorders. To test this,
TRF lengths in fibroblast cultures from Hutchinson-Gilford
progeria patients were compared with those from age-
matched normal individuals. We found that the pooled mean
TRF length in five cell strains established from progeria
donors, all of which had reduced proliferative capacity in
vitro (ref. 34 and unpublished data), was significantly shorter
than the corresponding value for five young normal donors
(Fig. 3; P < 0.001). The reduction in both telomere length and
replicative capacity in fibroblasts from the progeria donors is
further evidence that telomere length is a biomarker of
cellular aging. The mean TRF length in fibroblasts of parents
of progeria patients, who reveal no signs of premature aging,
was not different than that of age-matched normal donors
(Fig. 3B). This result is consistent with the suggestion that
Hutchinson-Gilford progeria arises from a de novo autoso-
mal dominant mutation (for review, see ref. 35). The short
telomeres characteristic of progeric fibroblasts could be
caused by abnormal regulation of telomere length in a pa-
rental germ-line clone, a high rate of cell turnover during
development of progeric individuals, or an aberrantly high
rate of telomere loss with each cell division. To test the later
possibility, we compared telomere loss during aging of fibro-
blasts from three progeria patients in vitro to that of age-
matched normal donors. There was a small and statistically
insignificant increase in the rate of telomere loss in the
fibroblasts from progeria patients (data not shown). Thus,
other factors are likely to contribute to the shortened telo-
meres seen in these cells.
Rates ofTelomere Loss in Vivo and in Vitro Are Comparable.
Based on data presented here, it is possible to estimate the
rate of telomere shortening per cell doubling in vivo. The rate
of decline of proliferative capacity of fibroblasts in vitro as a
function of donor age is =0.2 population doublings per yr
(refs. 2 and 3, and Fig. 2A). In the same donors, mean TRF
length decreased -15 bp per yr (Figs. 1 and 2B). Ifwe assume
that the loss of culture life-span with donor age reflects the
average cell doubling rate in vivo (i.e., that the total number
of doublings in vivo and in vitro is constant for a given
population of cells), then we obtain =75 bp per population
doubling for the in vivo rate of telomere shortening in human
fibroblasts. This rate is similar to that observed for telomere
shortening in vitro (48 + 21 bp per population doubling) (22,
25) but significantly greater than that for terminal DNA loss
in yeast defective for telomere maintenance (40) or in Dro-
sophila mutants with broken chromosomes (41-43). Analysis
ofDNA loss in these organisms suggested that as few as 2-4
bp were lost from the end of the chromosome per cell
doubling. However, many factors could account for the
difference between rates of telomere loss in normal human
somatic cells and these eukaryotes, such as differences in the
extent of incomplete replication, telomerase activity, or
exonuclease activity.
Maintenance of Telomere Length in Sperm. Because the
germ-line lineage is immortal, a mechanism to maintain
telomere length must be active at some stage of germ-line
development. To test this, we measured mean TRF length for
sperm from 63 donors ranging in age from 19 to 68 yr and
found that it increased slightly with age (Fig. 4). Analysis of
the integrated signal from the telomeric probe hybridized to
the TRFs showed greater experimental variation but also
indicated that theTTAGGG abundance did not decrease with
age (data not shown). These observations are consistent with
the idea that telomerase may be active in germ-line tissue,
10116 Biochemistry: Allsopp et al.
.
Proc. Nadl. Acad. Sci. USA 89 (1992)
A Progeria Aged-matched controls
MPD: 37 33 38 41 21 25 37 37 37 37
1 2 3 4 5 6 7 8 9 10
*
- ..~~~~~~~~~~.
................
%i\ s.-s ~i
21-_ '
12.
9-8o-
6-IT
4-|
1 2
10
0L
-,I 8
zCD
a)
a:
1-
CD
3-
2-
Age (yr)
Progeria Control Parent Control
0-14 9-14 30-42 31-42
FIG. 3. Comparison ofmean TRF length forfibroblast strains established from progeria donors and age-matched controls. (A) Genomic DNA
prepared from skin fibroblast cultures established from Hutchinson-Gilford (progeria) and normal donors at the indicated MPDs was analyzed
as described in Fig. lB. Size and position of markers are indicated. The donor age and maximum replicative capacity of the strains in lanes 1-10
are 0, 3, 3, 4, 14, 9, 10, 14, 12, and 15 yr and 37, 33, 41, 54, 26, 54, 73, 73, 73, 79 population doublings, respectively. (B) The pooled mean TRF
length for the progeria donors is significantly less than that for controls (P < 0.001). Comparison of pooled mean TRF length for the parents
of progeria patients and age-matched controls showed no significant difference (P > 0.1). Because DNA could not be obtained at equivalent
passage or donor age for all comparisons, mean TRF length was determined for normal donor strains at equal or greater population doublings
or donor age.
thus maintaining telomere length between generations of the
organism.
The Telomere Hypothesis. Telomerase can be detected in a
variety of immortal tumor cell lines and transformed cells in
culture (26, 30) but not in normal fibroblasts or embryonic
kidney cells (ref. 26, and A. Avilion and C.W.G., unpub-
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FIG. 4. Mean TRF length in sperm DNA increases as a function
of donor age in vivo. Mean TRF length was determined for semen
samples from 63 donors who ranged in age from 19 to 68 yr. SDs for
points representing the mean of two or more determinations are-
indicated. The slope of the regression line is 71 bp per yr and is
significantly different from 0 (P = 0.01). Values for the slope (m),
regression coefficient (r), and probability (P; H.: slope = 0) of the
linear regression line are shown.
lished data). The loss oftelomericDNA during aging ofhuman
fibroblasts (22), keratinocytes (23), leukocytes (24), epithelial
cells (24, 26), and endothelial cells (E. Chang and C.B.H.,
unpublished data) is consistent with a general lack of telom-
erase in untransformed somatic cells. These observations,
together with maintenance oftelomere length in germ-line cells
(Fig. 4), suggest a role for telomeres and telomerase in cell
aging and immortalization (Fig. 5). We suggest that telomerase
is (i) active in germ-line cells, (ii) repressed early in embryonic
development in most somatic cells, and (iii) reactivated in
somatic cells immortalized during tumorigenesis.
Counter et al. (26) showed that simian virus 40 large T
antigen and adenovirus 5 oncogenes can extend the life-span
of human embryonic kidney cells without directly activating
telomerase. Hence, during the extended life-span phase of
these cultures, telomeres continued to shorten until a "cri-
sis" point, when most cells die. Telomerase was detected
only in the relatively rare immortal clones that survived
crisis, and in these cells telomere length was stable. The two
breakpoints in Fig. 5 representing replicative senescence and
crisis correspond to mortality phase 1 (Ml) and mortality
phase 2 (M2), as defined by Wright et al. (44). The mean
telomere length at these points are designated Ti and T2. We
assume that Ml is a checkpoint in cell growth when one or
more telomeres reach a critical minimum length. Viral on-
cogenes and other agents may be able to bypass this check-
point without activating telomerase, thus compromising ge-
netic stability while telomeres continue to shorten. At M2,
telomere length may be severely shortened on many chro-
mosomes, leading to a dramatic increase in chromosomal
instability and cell death (26). Cells that activate telomerase
and stabilize telomere length may be able to survive M2.
Some studies with mice, a short-lived species, have shown
that TRFs are long and that their length does not decrease
noticeably with age (38, 39). However, because TRF lengths
in the strains of mice examined were very heterogeneous,
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FIG. 5. Schematic of the telomere hypothesis of cell aging and
immortalization. Changes in telomere length with passage of time (in
cell divisions) are represented for germ line, normal somatic, and
transformed cells. Events during early embryonic development at the
beginning of the time axis are uncertain (dotted lines). Telomerase is
presumably activated at some point in gametogenesis because telo-
mere length is maintained in germ-line cells, but it is not known
whether telomerase is active in the early embryo before germ-line
development. In contrast, the observed decrease in telomere length
and lack of telomerase activity in normal somatic cells suggest
repression of telomerase in these cells. At the Hayflick limit (Ml), we
assume that one or more telomeres have lost a threshold amount of
TTAGGG, signaling a checkpoint in cell growth (see text). Mean
telomere length at this point is designated Ti. Partially transformed
cells that bypass this checkpoint without activation of telomerase
continue to lose telomeres until "crisis" (M2), when most cells have
critically short telomeres on many chromosomes (mean telomere
length = T2). Cells that activate telomerase, presumably by muta-
tion, may survive crisis. Telomeres can then be stably maintained at
any length. (Graph was modified from ref. 13.)
both in total length and number of TTAGGG repeats, TRFs
with few telomeric repeats could have been obscured by the
strong signal from other TRFs with long telomeric arrays. In
this case; loss of a few hundred base pairs from short
telomeric dhrrys could be important to cellular aging but go
undetected. thus, the role of telomere loss in replicative
senescence of murine cells remains uncertain.
The dominance of senescence over immortality in hybrids
between mortal and immortal cells (for review, see ref. 45)
could be explained by a trans-acting repressor of telomerase
in the mortal cell parent. The existence of complementation
groups in transformed cells defined by the presence of a
mortal phenotype in hybrids between different immortal cells
(46, 47) is more difficult, but not impossible, to explain with
the telomere hypothesis. However, cells senesce and orga-
nisms age for many different reasons, and it is certain that
telomeres and telomerase are not involved in all aspects of
this multifactorial process (13).
In summary, our observations suggest that the gradual
shortening of telomeres in human somatic cells that lack
telomerase provides a good marker of replicative capacity in
vitro and in vivo. Moreover, the tight correlation of telomere
length to replicative capacity suggests that telomere loss may
initiate cell cycle exit once a critical or "threshold" number
of telomeric TTAGGG repeats is reached. It should be
possible to test whether telomere loss and telomerase ex-
pression are coincidental or causal in cell senescence and
immortalization once methods become available to alter
these activities in multicellular eukaryotes.
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